Publications by authors named "Ma Elena Velazquez-Meza"
In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.
Jesus Silva-Sanchez Fernando Reyna-Flores Ma Elena Velazquez-Meza Teresa Rojas-Moreno Arturo Benitez-Diaz
Diagn Microbiol Infect Dis
June 2011
Article Synopsis
- The study focused on the effectiveness of tigecycline against ESBL-producing Enterobacteriaceae and MRSA, which are significant hospital-associated infections.
- More than 94% of the tested bacterial isolates were found to be susceptible to tigecycline.
- The minimum inhibitory concentration (MIC) values indicated that tigecycline works well, especially at low concentrations (0.25 to 2 mg/L for ESBL bacteria and 0.125 mg/L for MRSA).